These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Living-donor liver transplantation for hepatocellular carcinoma. Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K. Transplantation; 2003 Feb 15; 75(3 Suppl):S37-40. PubMed ID: 12589138 [Abstract] [Full Text] [Related]
43. Is Macroscopic Portal Vein Tumor Thrombosis of HCC Really an Exclusion for Liver Transplantation? Aydin C, Yilmaz S. J Gastrointest Cancer; 2020 Dec 15; 51(4):1137-1140. PubMed ID: 32833219 [Abstract] [Full Text] [Related]
44. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study. Azoulay D, Audureau E, Bhangui P, Belghiti J, Boillot O, Andreani P, Castaing D, Cherqui D, Irtan S, Calmus Y, Chazouillères O, Soubrane O, Luciani A, Feray C. Ann Surg; 2017 Dec 15; 266(6):1035-1044. PubMed ID: 27617853 [Abstract] [Full Text] [Related]
45. Late recurrence of hepatocellular carcinoma after liver transplantation. Chok KS, Chan SC, Cheung TT, Chan AC, Fan ST, Lo CM. World J Surg; 2011 Sep 15; 35(9):2058-62. PubMed ID: 21597889 [Abstract] [Full Text] [Related]
47. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma. Yoon YI, Song GW, Lee SG, Hwang S, Kim KH, Kim SH, Kang WH, Cho HD, Jwa EK, Kwon JH, Tak EY, Kirchner VA. J Hepatol; 2018 Jun 15; 68(6):1153-1162. PubMed ID: 29452208 [Abstract] [Full Text] [Related]
51. Living donor liver transplantation for hepatocellular carcinoma: is surgeon a prognostic factor? Sharma R. Indian J Gastroenterol; 2009 Dec 15; 28(2):78; author reply 78-9. PubMed ID: 19696998 [No Abstract] [Full Text] [Related]
53. Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation. Harada N, Shirabe K, Ikeda Y, Korenaga D, Takenaka K, Maehara Y. Ann Transplant; 2012 Dec 31; 17(4):11-20. PubMed ID: 23274319 [Abstract] [Full Text] [Related]
54. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses. Wong TCL, Ng KKC, Fung JYY, Chan AAC, Cheung TT, Chok KSH, Dai JWC, Lo CM. Ann Surg Oncol; 2019 May 31; 26(5):1454-1462. PubMed ID: 30737669 [Abstract] [Full Text] [Related]
55. Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions. Pavel MC, Fuster J. World J Gastroenterol; 2018 Aug 28; 24(32):3626-3636. PubMed ID: 30166858 [Abstract] [Full Text] [Related]
56. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation. Rosenkrantz AB, Campbell N, Wehrli N, Triolo MJ, Kim S. Radiology; 2015 Feb 28; 274(2):426-33. PubMed ID: 25299785 [Abstract] [Full Text] [Related]
58. Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantation. Kishi Y, Sugawara Y, Tamura S, Kaneko J, Kokudo N, Makuuchi M. Transpl Int; 2006 Sep 28; 19(9):720-5. PubMed ID: 16918532 [Abstract] [Full Text] [Related]
60. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience. Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT, Fan ST. J Hepatobiliary Pancreat Sci; 2010 Sep 28; 17(5):548-54. PubMed ID: 19760139 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]